---
category: news
title: "Progenics Pharmaceuticals Announces Phase 3 CONDOR Trial of PyLâ„¢ in Prostate Cancer Achieved Primary Endpoint"
excerpt: "NEW YORK, Dec. 23, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology company developing innovative targeted medicines and artificial intelligence to find ... conventional imaging and/or changes in PSA levels following radiation therapy. Safety results showed PyL was well tolerated, consistent with the Phase ..."
publishedDateTime: 2019-12-23T12:00:00Z
sourceUrl: https://www.globenewswire.com/news-release/2019/12/23/1964007/0/en/Progenics-Pharmaceuticals-Announces-Phase-3-CONDOR-Trial-of-PyL-in-Prostate-Cancer-Achieved-Primary-Endpoint.html
type: article
quality: 0
heat: -1
published: false

provider:
  name: GlobeNewswire
  domain: globenewswire.com

topics:
  - AI
  - AI in Healthcare

related:
  - title: "Progenics Pharmaceuticals Announces Phase 3 CONDOR Trial of PyL(TM) in Prostate Cancer Achieved Primary Endpoint"
    excerpt: "About PROGENICS Progenics is an oncology company focused on the development and commercialization of innovative targeted medicines and artificial intelligence to find ... who require systemic anticancer therapy; and oral and subcutaneous formulations of RELISTOR (methylnaltrexone bromide) for the treatment of opioid-induced constipation ..."
    publishedDateTime: 2019-12-23T11:00:00Z
    sourceUrl: https://www.marketwatch.com/press-release/progenics-pharmaceuticals-announces-phase-3-condor-trial-of-pyltm-in-prostate-cancer-achieved-primary-endpoint-2019-12-23
    type: article
    provider:
      name: MarketWatch
      domain: marketwatch.com
    quality: 33
    images:
      - url: https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png
        width: 1200
        height: 630

secured: "nmfY64pZOpyDTgXEPbT1TI3fJLz4JxzXPpI4gT2boM3Z94OKlpPgtRRThIPcvMFnJDzAqD6kArGFX6V/s87beEkDAVJhbkCB2j5V0LunbP0I28cWsGxKBsj0e5QbsWuIbpQxLKjHPzI8xyiF8cMtrtXPywu/+gL9EJzFVlVAvuXvyADAKJE4z2bQZdZRu6jXfc41M0FYPi/xG0QqLYqwMmDa/efSMOf8eyUfAP6z5FfFKqhWjfMM4yoVtWjn6CueHVAQ2rS648Sz3ZI/4B+vbQ==;pQ5+0Hco4GzBO+qaUdTSNw=="
---

